[Featured Stock] ABL Bio Hits 52-Week High on Expectations for Bispecific Antibody Platform Potential

ABL Bio's stock price is showing strength. Expectations for the potential value of its bispecific antibody platform appear to be influencing the stock price.

At 9:34 AM on the 26th, ABL Bio was trading at 32,300 KRW, up 2.54% from the previous day. During the session, it rose to 33,000 KRW, marking a 52-week high.

Researcher Ha Taegi of Sangsangin Securities stated, "The potential value of various pipelines based on the bispecific antibody platform is expected to steadily increase," adding, "Based on this, the corporate value is also likely to continue trending upward."

Researcher Ha also added, "Although the recent stock price has risen significantly, making a short-term correction possible, considering the growth potential of the corporate value, there is still considerable room for the stock price to rise from a long-term perspective."